Jaakko Tuomilehto

发表

Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study

G Hu, J Tuomilehto, K Borch-Johnsen, 2004, Diabetologia.

The Unchanging Incidence of Hospitalization for Diabetic Nephropathy in a Population-Based Cohort of IDDM Patients in Finland

J. Tuomilehto, A. Reunanen, K. Borch-Johnsen, 1997, Diabetes Care.

Parental history of cardiovascular disease and risk of stroke. A prospective follow-up of 14371 middle-aged men and women in Finland.

E. Vartiainen, P. Jousilahti, J. Tuomilehto, 1997, Stroke.

Insulin sensitivity and insulin secretion in monozygotic and dizygotic twins

L. Groop, J. Kaprio, J. Eriksson, 2000, Diabetologia.

Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose.

J. Tuomilehto, J. Lindström, A. Nissinen, 2002, European heart journal.

Short stature and coronary heart disease: a 35‐year follow‐up of the Finnish cohorts of The Seven Countries Study

A. Nissinen, J. Tuomilehto, T. Forsén, 2000, Journal of internal medicine.

Long-term mortality among adults diagnosed with cancer during three decades in Finland

P. Jousilahti, S. Männistö, M. Artama, 2023, Frontiers in Cancer Control and Society.

Repeated Tissue Plasminogen Activator Treatment for Early Stroke Recurrence : Protocol Violation Is Not an Option

J. Tuomilehto, P. Jousilahti, Pekka Jousilahti, 2006 .

Repeated Tissue Plasminogen Activator Treatment for Early Stroke Recurrence : Protocol Violation Is Not an Option

Pekka Jousilahti, Jaakko Tuomilehto, 2006 .